Immediate radiotherapy best for prostate cancer:
This article was originally published in Clinica
Executive Summary
A US study has fuelled the debate over the best way to manage localised advanced prostate cancer after showing that men with the disease are more likely to survive if they undergo initial radiotherapy than opt for a watchful waiting policy. In an analysis of data from around 1,500 patients, a team, led by Dr Mack Roach of the University of California, San Francisco, found that the radiotherapy group had a greater chance of surviving 10 years compared with the watchful waiting group. The study appears in the March edition of The Journal of Urology.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.